Gonadorelin Acetate | Research Use Only

What it is

Gonadorelin acetate is the acetate salt form of gonadorelin, the synthetic form of gonadotropin-releasing hormone, commonly abbreviated GnRH. In the scientific literature, gonadorelin is described as a hypothalamic decapeptide that binds GnRH receptors and regulates gonadotropin signaling, which is why it is widely used in endocrine and receptor-signaling research.

Origins and scientific context

Gonadorelin is not a lengthened analog like some newer GnRH agonists, but rather a synthetic preparation of the native GnRH sequence itself. Reviews of GnRH biology and analog development distinguish native gonadorelin from modified agonists by noting that many longer-acting GnRH analogues are created through amino acid substitutions, whereas gonadorelin reflects the original decapeptide framework used in physiologic receptor signaling studies.

Molecular profile

Gonadorelin is a decapeptide with the commonly referenced sequence pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2. PubChem lists gonadorelin with the molecular formula C55H75N17O13, while the acetate form is listed separately as gonadorelin acetate with molecular formula C57H79N17O15 and molecular weight of about 1242.3 g/mol.

Scientific overview

In simplified terms, gonadorelin acetate is used in research to study GnRH receptor activation, gonadotropin signaling, and hypothalamic-pituitary-gonadal axis biology. Because gonadorelin represents the native GnRH signal rather than a heavily modified analogue, it is useful in experimental systems focused on receptor binding, endocrine signaling patterns, and comparative studies against longer-acting GnRH agonists or antagonists.

What researchers study with Gonadorelin Acetate

Key research focus areas often include
• GnRH receptor signaling pathways
• Hypothalamic-pituitary-gonadal axis models
• Gonadotropin release and endocrine-response studies
• Comparative studies of native GnRH versus synthetic GnRH analogues

Regulatory and compliance notice

Research Use Only. Not for human or veterinary use. This description is provided for scientific context and must not be used to market gonadorelin acetate for diagnosis, cure, mitigation, treatment, or prevention of disease.

Citations and references

PubChem compound entry for Gonadorelin Acetate, includes molecular formula and molecular weight.

PubChem compound entry for Gonadorelin, identifies gonadorelin as gonadotropin-releasing hormone and includes compound information.

DailyMed Fertagyl label, includes the gonadorelin amino acid sequence and molecular weight for gonadorelin.

Torrini et al. biomimetic ELISA paper, describes gonadorelin as gonadotropin-releasing hormone produced by the hypothalamus and outlines its signaling context.

Ortmann et al. review on gonadotropin-releasing hormone and its analogues, explains receptor signaling and the distinction between native GnRH and analogues.